JPMorgan Chase & Co’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-549
Closed -$127 6659
2024
Q4
$127 Hold
549
﹤0.01% 5923
2024
Q3
$1.18K Hold
549
﹤0.01% 5635
2024
Q2
$2.83K Hold
549
﹤0.01% 5464
2024
Q1
$2.94K Hold
549
﹤0.01% 5522
2023
Q4
$4.28K Sell
549
-528
-49% -$4.11K ﹤0.01% 5555
2023
Q3
$4.25K Buy
1,077
+481
+81% +$1.9K ﹤0.01% 5452
2023
Q2
$1.88K Hold
596
﹤0.01% 5444
2023
Q1
$2K Hold
596
﹤0.01% 5582
2022
Q4
$2K Sell
596
-116
-16% -$389 ﹤0.01% 5400
2022
Q3
$5K Buy
712
+421
+145% +$2.96K ﹤0.01% 5201
2022
Q2
$3K Sell
291
-3,163
-92% -$32.6K ﹤0.01% 5388
2022
Q1
$41K Buy
3,454
+677
+24% +$8.04K ﹤0.01% 5083
2021
Q4
$91K Buy
2,777
+111
+4% +$3.64K ﹤0.01% 4869
2021
Q3
$120K Sell
2,666
-15,689
-85% -$706K ﹤0.01% 4636
2021
Q2
$1M Sell
18,355
-48,036
-72% -$2.62M ﹤0.01% 3634
2021
Q1
$4.97M Sell
66,391
-7,196
-10% -$538K ﹤0.01% 2652
2020
Q4
$7.98M Buy
73,587
+314
+0.4% +$34.1K ﹤0.01% 2073
2020
Q3
$7.01M Sell
73,273
-6,052
-8% -$579K ﹤0.01% 1998
2020
Q2
$8.46M Sell
79,325
-8,829
-10% -$941K ﹤0.01% 1802
2020
Q1
$5.23M Sell
88,154
-6,455
-7% -$383K ﹤0.01% 1971
2019
Q4
$6.54M Buy
94,609
+52,550
+125% +$3.63M ﹤0.01% 2026
2019
Q3
$4.37M Buy
42,059
+1,275
+3% +$132K ﹤0.01% 2276
2019
Q2
$3.24M Buy
40,784
+677
+2% +$53.8K ﹤0.01% 2389
2019
Q1
$3.67M Sell
40,107
-69
-0.2% -$6.31K ﹤0.01% 2291
2018
Q4
$2.24M Buy
40,176
+3,180
+9% +$177K ﹤0.01% 2590
2018
Q3
$4.41M Buy
36,996
+829
+2% +$98.7K ﹤0.01% 2315
2018
Q2
$3.69M Sell
36,167
-1,284
-3% -$131K ﹤0.01% 2439
2018
Q1
$4.86M Buy
37,451
+4,571
+14% +$593K ﹤0.01% 2227
2017
Q4
$3.2M Buy
32,880
+20,227
+160% +$1.97M ﹤0.01% 2508
2017
Q3
$1.93M Buy
12,653
+1,733
+16% +$264K ﹤0.01% 2651
2017
Q2
$1.76M Sell
10,920
-1,136
-9% -$183K ﹤0.01% 2669
2017
Q1
$1.92M Sell
12,056
-856
-7% -$136K ﹤0.01% 2619
2016
Q4
$1.57M Sell
12,912
-729
-5% -$88.6K ﹤0.01% 2804
2016
Q3
$1.89M Buy
+13,641
New +$1.89M ﹤0.01% 2489